Zucara Therapeutics Announces Strategic Investment from Sanofi as Part of US$20 Million Series B Financing
– Sanofi and Existing Investor, Perceptive Advisors’ PXV Fund I, Invested a combined US$20 million as part of the Financing – – Sanofi to Receive Exclusive Right of First Negotiation – – Proceeds to Fund Remainder…